Comment
There have been continuous efforts in the syntheses of a vaiiety of functionalized carborane derivatives for use in the treatment of cancer by boron neutron capture therapy (BNCT) [1] [2] [3] [4] [5] , One of the functionalized carborane derivatives has been the l-(phthalimidomethyl)-l,2-dicarba-c/oso-dodecaborane (2) that has been used as a synthon for a number of aminoalkylcarborane derivatives. Since the functionalized carborane compounds can be converted to the corresponding open-cage dianionic C 2 Bo or C : Bio-carborane ligand with the intact functional moiety, l-(methyl)-2-(phthaIimidomethyl)-l,2-dicarba-c/oio-dodecaborane (1) was synthesized as the precursor for the preparation of group 4 metal complexed carborane catalysts and its unambiguous molecular geometry was confirmed by single-crystal X-ray crystallography as reported herein. Compound 2 has been known since 1970 [6] , but its solid-state geometry was only recently reported by Tiekink [7] . The crystal structure of the title compound (Figure 1 ) reveals that the molecule is a closed polyhedron with a distorted icosahedral geometry which represents a new polymoreph. The bond distances of 1.671(3) Ä between the cage carbons in 1 is slightly longer than the corresponding C-C bond length of 1.635(3) A in 2. However, the exo-polyhedral C (c , 8 erQmethyi) and C( Cas erC(phihaiin.idomeihyi)distances of 1.509(3) and 1.527(3) Ä, respectively, are comparable to that of 1.518(3) Ä in 2. The remaining intra-cage bond lengths and the bond angles are normal within the allowed errors of estimations.
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Synthesis:
In a procedure, identical to that reported elsewhere [8] , the title compound (1) was synthesized in 83% yield by refluxing equimolar amounts of l-phthalimido-2-butyne and decaborane(14)-acetonitrile adducts in toluene, followed by recrystallization from toluene. 
